Phase I/II trial of dose-reduced capecitabine in elderly patients with advanced colorectal cancer

BACKGROUND: Combination chemotherapy is associated with improved outcomes in trials of selected fit patients with advanced colorectal cancer (acrc). For older or less-fit patients, combination chemotherapy is associated with greater toxicity and less benefit. Capecitabine monotherapy is a reasonable...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Curr Oncol
Autori principali: Vincent, M.D., Breadner, D., Cripps, M.C., Jonker, D.J., Klimo, P., Biagi, J.J., Lam, W., O’Connell, A., Whiston, F., Stitt, L., Welch, S.A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Multimed Inc. 2017
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5576465/
https://ncbi.nlm.nih.gov/pubmed/28874896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.24.3516
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi